Investment Group

Pharma Equity Group is a Danish biopharmaceutical investment company primarily focused on the development of innovative medical treatments through its subsidiary, Reponex Pharmaceuticals. The company specializes in repositioning existing drugs for new therapeutic applications, particularly in the areas of chronic inflammatory diseases and cancer. Its lead programs utilize local drug administration to maximize efficacy and minimize systemic side effects. Key candidates in the pipeline target conditions such as chronic non-healing wounds, inflammatory bowel disease, and colorectal cancer. By leveraging a risk-mitigated development strategy, Pharma Equity Group aims to address significant unmet medical needs while optimizing the path to commercialization.